Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 737 results for "sandoz inc"

The COPAXONE story in the U.S. and India: a further update

As an update to our March 5th and April 4th postings, and , the U.S. Supreme Court (Supreme Court) yesterday asked Sandoz Inc. (Sandoz) and Mylan Inc. (Mylan) to respond to Teva Pharmaceutical Industries Ltd.'s (Teva) application to recall and stay ... Lexology, 4 days ago

2 images for "sandoz inc"

Scottrade, 5 months ago
Drug Discovery and Development, 4 months ago

Generic-Drug Makers Oppose Teva Bid to Delay Copaxone Rivals

Generic-drug makers including Momenta Pharmaceuticals Inc. In a court filing today, Momenta, Novartis AG's Sandoz and Mylan Inc. said they would suffer "immense harm" if barred from selling generic Copaxone in the U.S. after some of the drug's ...
 BusinessWeek1 week ago Teva's Generic Copaxone Rivals Asked to Respond on Delay  Bloomberg2 weeks ago
[x]  

Sandoz launches generic version of Prevpac

PRINCETON, N.J. Sandoz Inc. has rolled out lansoprazole capsules, amoxicillin capsules and clarithromycin tablets, a generic version of the combination medicine Prevpac from Takeda Pharmaceuticals. The Novartis subsidiary said Thursday that it's ...
 Chain Drug Review3 weeks ago Sandoz launches H. pylori infection therapy in US  Individual.com3 weeks ago

Update-Moody's: M&A among generic drug makers raises risk for investors

Teva Pharmaceutical Industries Ltd, Mylan Inc. , Actavis plc and Sandoz For the full text of this story please click the following link: http://www.moodys.com/page/viewresearchdoc.aspx-docid=PR_295755&WT.mc_id=NLTITLE_YYYYMMDD_PR_295755 ...
 Yahoo! Finance4 weeks ago Moody's: M&A among generic drug makers raises risk for investors  Capital Market3 weeks ago
[x]  

Novartis AG Names New Heads Of Alcon, Inc., Sandoz, Inc. Units

 BioSpace2 weeks ago Novartis : Names New Alcon, Sandoz Division Heads  4 Traders2 weeks ago Novartis Names New Alcon, Sandoz Division Heads ...  ADVFN UK2 weeks ago
[x]  

Global Biosimilar Market Outlook 2018

FEATURED COMPANIES 3 SBio Inc. Bioton Dr.Reddy's Labs (DRL) Hospira Ratiopharm GmbH Sandoz GmbH MORE The global biosimilars market is at a crucial turning point, as ...
 Research and Markets1 month ago Global Generic Drugs Market 2014-2018  Gnom.es2 days ago Global Generic Drugs market to grow at 11.02% CAGR over 2013-2018  News-Medical.Net2 days ago Global EPO Biosimilars Market Outlook 2018  Research and Markets1 month ago
[x]  
Chicago Tribune

Supreme Court Grants Certiorari in Teva Pharmaceuticals v. Sandoz

Earlier today, the Supreme Court granted certiorari in the Teva Pharmaceuticals USA, Inc. v. Sandoz Inc. case (Supreme Court docket number 13-854). The sole issue on appeal is encapsulated by the question presented: QUESTION PRESENTED: ...
 JD Supra3 weeks ago UPDATE 1-Teva asks U.S. Supreme court to stay ruling in Copaxone case  CNBC2 weeks ago Teva asks Supreme court to stay ruling in Copaxone case  Chicago Tribune2 weeks ago Teva asks U.S. Supreme court to stay ruling in Copaxone case  Sharenet2 weeks ago
[x]  

Impax hires Actavis exec as CEO

HAYWARD, Calif. G. Frederick Wilkinson is departing Actavis plc to join Impax Laboratories Inc. as president and chief executive officer. The specialty pharmaceutical company said Monday that Wilkinson is due to take the CEO reins on April 29. He ...
 Chain Drug Review2 days ago IMPAX Laboratories, Inc. Board Of Directors Appoints President And CEO  BioSpace2 days ago IMPAX LABORATORIES : Board of Directors Appoints G. Frederick Wilkinson President and CEO  4 Traders2 days ago Impax Board of Directors Appoints G. Frederick Wilkinson President and CEO  Asian Hospital & Healthcare Management1 day ago
[x]  
Citybizlist

Pernix Therapeutics Appoints John Sedor to Its Board of Directors

By a News Reporter-Staff News Editor at Biotech Week -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, announced the appointment of John Sedor as a non-executive Director and Chairman of the Compensation ...
 HispanicBusiness.com1 month ago PERNIX THERAPEUTICS HOLDINGS, INC. FILES (8-K) Disclosing Change in Directors or Principal Officers  TMC Net1 month ago PERNIX THERAPEUTICS : Appoints John Sedor to Its Board of Directors  4 Traders1 month ago Patent Issued for Cyclosporin Analogues  4 Traders1 week ago
[x]  

Teva asks U.S. justices to stay lower court ruling in Copaxone case

WASHINGTON, April 7 (Reuters) - Teva Pharmaceutical Industries Inc on Monday asked the U.S. Supreme Court to prevent an appeals court ruling from going into effect while the justices consider the company's appeal in a patent fight over top-selling ...
 CNBC2 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less